Heparin Effects on Serum Gonadotropins.

Area of Science:

• Endocrinology
• Metabolic Research

Background:

• Lipid infusion studies require heparin to release lipoprotein lipase (LPL).
• The use of heparin as a control raises questions about its effect on free fatty acids (FFAs) and gonadotropins.

Purpose of the Study:

• To evaluate if heparin, at doses needed to release LPL, alters circulating FFAs.
• To determine the effect of heparin on gonadotropin levels (FSH and LH).

Main Methods:

• Secondary analysis of data from eumenorrheic, normal-weight women in control conditions.
• Comparison of FSH and LH levels across groups receiving saline alone or saline plus heparin.
• Linear mixed models used for data analysis.

Main Results:

• No significant difference in luteinizing hormone (LH) levels across groups.
• Marginal differences in follicle-stimulating hormone (FSH) levels (P = .05) after adjustment for anti-Mullerian hormone, unrelated to heparin.

Conclusions:

• Heparin does not significantly impact gonadotropin levels at LPL-releasing doses.
• Heparin's ability to release other proteins suggests its inclusion in control infusions for lipid studies aiming to increase FFAs.